Bliss GVS Pharma
BSE 506197 · ISIN INE416D01022
8 stories, newest first.
- Board meeting on October 29, 2026 to consider and approve September quarter results
- Anupam Rasayan and Mates Visa acquired control; erstwhile promoters reclassified to public
- Bliss GVS Pharma Ltd: 47.95% of shares pledged
- Board approves Senior Executive ESOP 2026 and Employee ESOP 2026; options up to 26,50,000 and 47,00,000 shares
- Bliss GVS Pharma Ltd promoter buys 47.95% stake, holding rises to 50.07%^#%
- Bliss GVS shares fell 3% after promoter entity Anupam Rasayan bought the required 2% stake to cross the 50% ownership mark
- Anupam Rasayan, promoter entity of Bliss GVS, acquired an additional 2.12% stake to cross the 50% threshold after its earlier open offer failed
- Board Meeting on October 1, 2026 to Consider Two Employee Stock Option Plans
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.